Published in Oncotarget on March 29, 2016
Epidemiology of pancreatic cancer. World J Gastroenterol (2016) 0.78
Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain. Front Microbiol (2017) 0.78
Is It Rationale to Apply Strict Colonoscopic Surveillance in Patients with Helicobacter pylori Associated Chronic Atrophic Gastritis? Gut Liver (2016) 0.75
Factors associated with gastric adenocarcinoma and dysplasia in patients with chronic gastritis: a population-based study. Chin J Cancer Res (2017) 0.75
Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin. Inflammopharmacology (2017) 0.75
Associations of Helicobacter pylori infection and chronic atrophic gastritis with accelerated epigenetic ageing in older adults. Br J Cancer (2017) 0.75
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA (2004) 6.96
Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97
Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer (2004) 2.88
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol (2012) 1.89
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Association between Helicobacter pylori and mortality in the NHANES III study. Gut (2013) 1.74
Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer (2006) 1.64
Gastrin and colorectal cancer: a prospective study. Gastroenterology (1998) 1.57
The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis. Eur J Gastroenterol Hepatol (2013) 1.55
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res (2009) 1.33
Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control (2010) 1.18
Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev (2002) 1.14
Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.14
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev (2012) 1.13
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer (2013) 1.11
Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res (2009) 1.10
Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study. Scand J Gastroenterol (1997) 1.07
A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer (2008) 1.07
Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol (2014) 1.03
Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer (2007) 1.03
Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol (2008) 1.02
Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study. Eur J Epidemiol (2014) 1.01
Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter (2007) 0.98
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol (2011) 0.97
A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer (2013) 0.95
Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer (2010) 0.94
Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. Eur J Gastroenterol Hepatol (2013) 0.94
Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology (2009) 0.93
Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study. Clin Gastroenterol Hepatol (2012) 0.90
Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition. Int J Cancer (2008) 0.88
Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori? Helicobacter (1999) 0.88
Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.87
Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer Detect Prev (1999) 0.87
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol (2014) 0.86
Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One (2013) 0.85
Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev (2013) 0.85
Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol (2008) 0.85
Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med (2013) 0.83
Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects. Helicobacter (2013) 0.82
Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A Meta-Analysis Based on Nested Case-Control Studies. Pancreas (2015) 0.80
Helicobacter pylori and colonic neoplasms. Am J Gastroenterol (2013) 0.77
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol (2015) 2.95
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature (2014) 1.88
Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Cancer Lett (2014) 1.00
F2RL3 methylation, lung cancer incidence and mortality. Int J Cancer (2015) 0.89
Relationship of tobacco smoking and smoking-related DNA methylation with epigenetic age acceleration. Oncotarget (2016) 0.85
Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting. Clin Cancer Res (2015) 0.84
Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review. Clin Epigenetics (2016) 0.84
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer (2015) 0.83
Smoking and All-cause Mortality in Older Adults: Results From the CHANCES Consortium. Am J Prev Med (2015) 0.83
Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study. PLoS One (2015) 0.81
Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol (2015) 0.80
Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget (2016) 0.80
Viral infections and colorectal cancer: a systematic review of epidemiological studies. Int J Cancer (2014) 0.78
Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin. Int J Cancer (2017) 0.76
Smoking-associated DNA methylation markers predict lung cancer incidence. Clin Epigenetics (2016) 0.76
Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One (2016) 0.75
Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer. PLoS Genet (2016) 0.75
Plasma S100P level as a novel prognostic marker of metastatic breast cancer. Breast Cancer Res Treat (2016) 0.75
Frailty and healthcare costs-longitudinal results of a prospective cohort study. Age Ageing (2017) 0.75
Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine (2015) 0.75